KY HB 296
died on adjournmentAN ACT relating to psychotropic drugs.
Kentucky · 2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did KY HB 296 pass?
No. KY HB 296 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-16): to Health Services (H)
What is KY HB 296 about?
Create a new section of KRS Chapter 205 to define terms; require Medicaid-enrolled providers prescribing psychotropic drugs to children to provide an FDA Medication Guide to parents or legal guardians; require medical care providers prescribing psychotropic drugs to children covered by Medicaid to obtain signed informed consent from a parent or guardian; require the Cabinet for Health and Family Services to develop and maintain an adverse drug reaction online reporting system; require the cabinet to compile and submit an annual report of the adverse drug reaction online reporting system to the Legislative Research Commission; require the cabinet to submit an annual report summarizing the implementation efforts and compliance statistics of Medicaid-enrolled providers; establish penalties; require the cabinet to promulgate administrative regulations to implement the system.
Who sponsors KY HB 296?
M. Proctor, C. Massaroni, J. Calloway are the primary sponsors of KY HB 296.
Description
Create a new section of KRS Chapter 205 to define terms; require Medicaid-enrolled providers prescribing psychotropic drugs to children to provide an FDA Medication Guide to parents or legal guardians; require medical care providers prescribing psychotropic drugs to children covered by Medicaid to obtain signed informed consent from a parent or guardian; require the Cabinet for Health and Family Services to develop and maintain an adverse drug reaction online reporting system; require the cabinet to compile and submit an annual report of the adverse drug reaction online reporting system to the Legislative Research Commission; require the cabinet to submit an annual report summarizing the implementation efforts and compliance statistics of Medicaid-enrolled providers; establish penalties; require the cabinet to promulgate administrative regulations to implement the system.
- Introduced
- 2026-01-09
- Latest action
- 2026-01-16 — to Health Services (H)
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- M. Proctorprimary
- C. Massaroniprimary
- J. Callowayprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-01-16
to Health Services (H)
referral-committee
2026-01-09
to Committee on Committees (H)
referral-committee
2026-01-09
introduced in House
introduction
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:24.357326Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=KY&identifier=HB 296. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.